Literature DB >> 12650800

Identification and management of hepatitis C patients in primary care clinics.

Thomas M Shehab1, Mauricio Orrego, Renu Chunduri, Anna S F Lok.   

Abstract

OBJECTIVE: Previous survey-based research suggested that hepatitis C patients receive suboptimal care in primary care settings. The aim of our study was to define the actual level of care hepatitis C patients receive in primary care clinics.
METHODS: Medical records of 229 hepatitis C antibody-positive (group 1), 229 hepatitis C antibody-negative (group 2), and 229 patients not tested for hepatitis C antibody (group 3) were reviewed to assess the indications for hepatitis C testing and the subsequent management and referral of hepatitis C antibody-positive patients diagnosed in primary care clinics. In addition, the compliance of primary care physicians with hepatitis C screening and testing guidelines was assessed.
RESULTS: Only 16% of group 1 and 10% of group 2 patients were tested for hepatitis C based on physician-identified risk factors. Only 1% of group 3 patients had documented discussion of hepatitis C risk factors during their initial visit with a primary care physician. The majority of hepatitis C antibody-positive patients was appropriately evaluated in primary care clinics, and most (77%) hepatitis C RNA-positive patients with elevated liver enzymes were referred for subspecialty care. Of the 59 patients who underwent liver biopsy, 40% had bridging fibrosis or cirrhosis.
CONCLUSIONS: Hepatitis C testing is rarely initiated in primary care clinics based on physician-identified risk factors. Interventions should be developed to optimize early diagnosis of hepatitis C as significant liver disease may be present despite the absence of symptoms.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12650800     DOI: 10.1111/j.1572-0241.2003.07331.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  27 in total

1.  Duplicate hepatitis C antibody testing in New York City, 2006-2010.

Authors:  Victoria Tsai; Katherine Bornschlegel; Emily McGibbon; Stephen Arpadi
Journal:  Public Health Rep       Date:  2014 Nov-Dec       Impact factor: 2.792

Review 2.  A systematic review of provider knowledge of hepatitis C: is it enough for a complex disease?

Authors:  Susan L Zickmund; Kyle E Brown; Klaus Bielefeldt
Journal:  Dig Dis Sci       Date:  2007-04-04       Impact factor: 3.199

3.  Hepatitis C risk assessment, testing and referral for treatment in urban primary care: role of race and ethnicity.

Authors:  Stacey B Trooskin; Victor J Navarro; Robert J Winn; David J Axelrod; A Scott McNeal; Maricruz Velez; Steven K Herrine; Simona Rossi
Journal:  World J Gastroenterol       Date:  2007-02-21       Impact factor: 5.742

4.  Managing chronic hepatitis C in primary-care settings: more than antiviral therapy.

Authors:  Barry Zevin
Journal:  Public Health Rep       Date:  2007       Impact factor: 2.792

5.  Indications for testing among reported cases of HCV infection from enhanced hepatitis surveillance sites in the United States, 2004-2010.

Authors:  Reena Mahajan; Stephen J Liu; R Monina Klevens; Scott D Holmberg
Journal:  Am J Public Health       Date:  2013-06-13       Impact factor: 9.308

6.  Awareness of biologically confirmed HCV among a community residing sample of drug users in Baltimore City.

Authors:  Nicole Ennis Whitehead; Lauren E Hearn; Michael Marsiske; Maria R Kahn; William W Latimer
Journal:  J Community Health       Date:  2014-06

Review 7.  Demographics of hepatitis C virus today.

Authors:  Stevan A Gonzalez; Gary L Davis
Journal:  Clin Liver Dis (Hoboken)       Date:  2012-03-06

8.  Hepatitis C virus testing perspectives among primary care physicians in four large primary care settings.

Authors:  Amy Jewett; Arika Garg; Katherine Meyer; Laura Danielle Wagner; Katherine Krauskopf; Kimberly A Brown; Jen-Jung Pan; Omar Massoud; Bryce D Smith; David B Rein
Journal:  Health Promot Pract       Date:  2014-04-28

9.  Determinants of antiviral treatment initiation in a hepatitis C-infected population benefiting from universal health care coverage.

Authors:  Romain Moirand; Marc Bilodeau; Suzanne Brissette; Julie Bruneau
Journal:  Can J Gastroenterol       Date:  2007-06       Impact factor: 3.522

10.  Factors associated with seroprevalence of hepatitis C among dentists at a large Brazilian city.

Authors:  Vera Lúcia S Resende; Mauro Henrique G Abreu; Saul M Paiva; Rosângela Teixeira; Isabela A Pordeus
Journal:  Virol J       Date:  2009-12-23       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.